Release Date: 25/10/10 08:28 Summary: Chairman and CEO's Address to Shareholders Price Sensitive: No Download Document 358.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%